Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

This study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of different treatment strategies in patients with blood cancers. We want to know how these different treatments impact on your health and your use of healthcare services. This research project uses an Adaptive Platform Design. This design allows the researchers to compare multiple infection prevention strategies within t

Trial Details

NCT ID
NCT07202091
Phase
PHASE2 / PHASE3
Sponsor
Monash University
Status
RECRUITING
Cancer Type
Multiple Myeloma
Interventions
  • Trimethoprim Sulfamethoxazole
  • Amoxycillin/clavulanic acid
  • Immune Globulin Intravenous
Locations (sample)
  • Adelaide, South Australia, Australia|-34.92866,138.59863
  • Melbourne, Victoria, Australia|-37.814,144.96332
  • Melbourne, Victoria, Australia|-37.814,144.96332

Key Eligibility Criteria

  • Patients must be receiving Ig (IV or subcutaneous - SCIg) replacement for prevention of bacterial infections due to hypogammaglobulinaemia for at l…
  • Patient is eligible for trial of Ig cessation in the opinion of the treating clinician and local investigator.
  • Patient is willing and able to comply with each of the treatment arms.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Multiple Myeloma Trials on Trialify →